Aerie Pharmaceuticals Inc Logo Image

Aerie Pharmaceuticals Inc

Aerie Pharmaceuticals Inc Banner Image

Most Recent Annual Report

2018 Annual Report and Form 10K

Aerie Pharmaceuticals Inc

Archived Annual Reports

  • Aerie Pharmaceuticals Inc
  • Aerie Pharmaceuticals Inc

About Aerie Pharmaceuticals Inc

201-500 Employees
Based in Durham, North Carolina

Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of first-in-class therapies for the treatment of glaucoma and other eye diseases. Its product candidates include Rhopressa, which is a once-daily eye drop that reduces intraocular pressure (IOP) in patients with glaucoma or ocular hypertension and is in Phase III registration trials; and Roclatan, a once-daily eye drop to reduce IOP that has completed Phase IIb clinical trial in patients with open-angle glaucoma and ocular hypertension.

NASDAQ (See More NASDAQ Companies)
Drug Manufacturers - Major (See More Drug Manufacturers - Major Companies)
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol